2.Surveillance of antimicrobial susceptibility of urinary pathogens in a tertiary care hospital.
Subhash C ARYA ; Nirmala AGARWAL ; Shekhar AGARWAL
Singapore medical journal 2007;48(3):270-author reply 271
Anti-Bacterial Agents
;
therapeutic use
;
Ceftazidime
;
therapeutic use
;
Cross Infection
;
drug therapy
;
epidemiology
;
microbiology
;
Escherichia coli Infections
;
epidemiology
;
Gentamicins
;
therapeutic use
;
Humans
;
India
;
epidemiology
;
Klebsiella Infections
;
epidemiology
;
Microbial Sensitivity Tests
;
Proteus Infections
;
epidemiology
;
Pseudomonas Infections
;
epidemiology
;
Retrospective Studies
;
Urinary Tract Infections
;
drug therapy
;
epidemiology
;
microbiology
5.Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Subhash C ARYA ; Nirmala AGARWAL ; Bhavani S SOLANKI ; Shekhar AGARWAL
Singapore medical journal 2007;48(6):600-601
Anti-Bacterial Agents
;
therapeutic use
;
Cephalosporins
;
therapeutic use
;
Drug Resistance, Multiple, Bacterial
;
Escherichia coli
;
drug effects
;
Escherichia coli Infections
;
drug therapy
;
Hospitals, Urban
;
Humans
;
India
;
Intensive Care Units
;
Klebsiella Infections
;
drug therapy
;
Klebsiella pneumoniae
;
drug effects
;
Microbial Sensitivity Tests
;
Penicillanic Acid
;
analogs & derivatives
;
therapeutic use
;
Piperacillin
;
therapeutic use
;
Sepsis
;
drug therapy
;
Thienamycins
;
therapeutic use
;
beta-Lactamases
;
analysis
;
drug effects